ARCHIVES

M.D. Anderson Closes Trials following FDA Requests for Data

This article is from The Cancer Letter archive.

Vol. 22 No. 07 | February 16, 1996

Download PDF Visit The Full Archive

Related Articles

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

In Brief: Allegheny Wins NSABP Recompetition; Luri Cancer Center Hosts Princess Diana

June 14, 1996

NCAB Committee Approves NCI Plans For Organ Systems

February 5, 1988

Cancer Informatics: NCI Calls On Users To Help Redesign Physician’s Data Query

February 13, 1998

NCAB Urges $2 Tax On Cigarettes To Reduce Smoking

February 12, 1993

Lifestyle Changes Common After Cancer Diagnosis

August 26, 2005